切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 71 -75. doi: 10.11817/j.issn.1673-9248.2022.02.001

专家论坛

2021年我国脑卒中防治主要工作进展回顾及2022年工作规划
巢宝华1, 王凌霄1, 樊帅1, 涂文军1, 曹雷1, 王陇德1,()   
  1. 1. 100053 北京,国家卫生健康委员会脑卒中防治工程委员会办公室
  • 收稿日期:2022-03-16 出版日期:2022-04-01
  • 通信作者: 王陇德

Stroke prevention and control in China: round-up 2021 and prospects 2022

Baohua Chao1, Lingxiao Wang1, Shuai Fan1, Wenjun Tu1, Lei Cao1, Longde Wang1,()   

  1. 1. The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing 100053, China
  • Received:2022-03-16 Published:2022-04-01
  • Corresponding author: Longde Wang
引用本文:

巢宝华, 王凌霄, 樊帅, 涂文军, 曹雷, 王陇德. 2021年我国脑卒中防治主要工作进展回顾及2022年工作规划[J]. 中华脑血管病杂志(电子版), 2022, 16(02): 71-75.

Baohua Chao, Lingxiao Wang, Shuai Fan, Wenjun Tu, Lei Cao, Longde Wang. Stroke prevention and control in China: round-up 2021 and prospects 2022[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(02): 71-75.

脑卒中是我国居民致死致残的主要原因。为了应对卒中挑战,2011 年 4 月,原卫生部中国脑卒中防治工程委员会(CSPPC)成立,该委员会积极推动中国脑卒中预防和控制工作。2021年CSPPC有序推进脑卒中高危人群筛查和干预、卒中中心建设、适宜技术推广、专病分级诊疗、健康宣教等工作,取得了优异成绩。在2022年,CSPPC将主要开展以下工作:加强卒中中心建设,推进区域协作工作;加强适宜技术培训,提升卒中救治成效;高质量开展脑卒中高危人群筛查工作;持续普及健康知识;深入开展患者随访管理,提升全民健康素养。

Stroke is one of the leading causes of mortality and disability in China. Facing the challenge of stroke, China Stroke Prevention Project Committee (CSPPC) was established in April 2011 under the leading of the Ministry of Health. The CSPPC actively promotes and stroke prevention and control in China. In 2021, CSPPC has obtained remarkable achievements as following: high-risk stroke population screening and the relevant intervention, construction of stroke centers, promotion of appropriate stroke treatment technologies, tiered diagnosis and treatment of stroke, and health education. In 2022, CSPPC will mainly carry out the following tasks: strengthening the construction of stroke centers and promote regional collaboration; strengthening appropriate technical training to improve the effectiveness of stroke treatment; carrying out high-quality screening of high-risk stroke populations; continuing to popularize health knowledge; perfroming follow up of patients with stroke and improving the health education in general population.

1
Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study [J]. BMJ, 2020, 369: m997.
2
Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project) [J]. Lancet, 2017, 390(10112): 2549-2558.
3
Tu WJ, Zeng X, Liu Q. Aging tsunami coming: the main finding from China’s seventh national population census [J]. Aging Clin Exp Res, 2021. Online ahead of print.
4
Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: CSPPC-stroke program [J]. Int J Stroke, 2021, 16(3): 265-272.
5
Tu WJ, Yan F, Chao BH, et al. Stroke-unit care for stroke patients in China: the results from bigdata observatory platform for stroke of China [J]. J Neurol, 2021, 268(11): 4213-4220.
6
Geng C, Li SD, Zhang DD, et al. Endovascular thrombectomy versus bridging thrombolysis: real‐world efficacy and safety analysis based on a nationwide registry study [J]. J Am Heart Assoc, 2021, 10(3): e018003.
7
Tu WJ, Chao BH, Ma L, et al. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China [J]. Brain Res Bull, 2021, 175: 130-135.
8
Tu W, Yan F, Chao B, et al. Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018 [J]. Front Med, 2021, 15(6): 903-912.
9
Zi W, Qiu Z, Li F, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial [J]. JAMA, 2021, 325(3): 234-243.
10
Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA [J]. N Engl J Med, 2021, 385(27): 2520-2530.
11
Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death [J]. N Engl J Med, 2021, 385(12): 1067-1077.
12
Lu X, Niu X, Shen C, et al. Development and validation of a polygenic risk score for stroke in the Chinese population [J]. Neurology, 2021, 97(6): e619-e628.
[1] 李振华, 解宝江, 易为, 李丽, 卫雅娴, 周明书, 伊诺. 82例孕产妇对新型冠状病毒肺炎疫情防控认知的心理干预及常态化疫情防控应对要点[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 173-179.
[2] 李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[3] 龙卫兵, 刘晓冰, 易仁政, 邹德博, 蒋玉斌, 陈亮, 谢超群, 刘红叶, 粟周华, 张雄峰, 李麒麟. CT、B超预定位"三步法"经皮肾镜治疗上尿路结石[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 587-592.
[4] 马俊永, 王毅州, 李锡锋, 吴雅丽, 张小峰. 浅谈腹腔镜肝切除术出血防控策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 495-498.
[5] 娜荷雅, 朱丹. 红光疗法在儿童近视眼防控中的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 252-256.
[6] 尚慧娟, 袁晓冬. 机械取栓术后应用依达拉奉右崁醇对急性缺血性脑卒中预后的改善[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 295-301.
[7] 廖家权, 吴波, 唐昌敏. 体外冲击波联合肌电生物反馈对脑卒中后足下垂的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 286-292.
[8] 许方军, 曹晓光, 王修敏, 董学超, 刘云卫, 彭云飞, 周康. 虚拟情景互动技术联合肩胛骨运动控制强化训练对偏瘫患者上肢功能及日常生活活动能力的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 222-228.
[9] 侯牧韶, 刘子渤, 李红玲. 局部振动疗法治疗脑卒中后运动障碍的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 246-250.
[10] 孙畅, 赵世刚, 白文婷. 脑卒中后认知障碍与内分泌激素变化的关系[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 471-476.
[11] 张许平, 刘佳成, 张舸, 杜艳姣, 李韶, 商丹丹, 王浩, 李艳, 段智慧. CYP2C19基因多态性联合血栓弹力图指导大动脉粥样硬化型非致残性缺血性脑血管事件患者抗血小板治疗的效果[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 477-481.
[12] 杨海华, 袁景林, 周晓梅, 牛军伟. RNF213基因突变所致烟雾病一家系病例临床分析并文献复习[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 495-498.
[13] 李昕, 李永凯, 江树青, 夏来百提姑·赛买提, 杨建中. 急性缺血性脑卒中静脉溶栓后出血转化相关危险因素分析[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 331-336.
[14] 邓颖, 黄山, 胡慧秀, 孙超. 老年缺血性脑卒中患者危险因素聚集情况分析[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 344-349.
[15] 祁研, 张岩, 陈雪, 刘颖, 史楠. 探讨高低频交互rTMS对老年脑卒中偏瘫患者肢体功能、吞咽功能及日常生活活动能力的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 359-363.
阅读次数
全文


摘要